Gene Query: SPIRE2

Dataset Description Geneva Score
Transcriptomic analysis of human tonsillar TFH subsets 39.38
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 27.68
PTHrP overexpression in MCF7 cells 19.38
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 18.82
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 17.77
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 16.47
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 16.33
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 16.06
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 16.02
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 15.44
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 15.44
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 14.69
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 13.56
Primary human trophoblast from term placenta 13.35
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 12.52
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 12.46
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 10.88
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 10.7
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 10.49
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 10.21
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 10.03
RNA-Sequencing of HepG2 cells treated with TGFBeta 9.74
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 9.59
Transcriptome analysis in Neobractatin treated cells 9.36
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 9.23
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 9.14
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 9.09
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 9.08
High-Throughput Kinetic Analysis of Fractional Killing 8.8
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 8.55
MOF acetyl transferase regulates transcription and respiration in mitochondria 8.38
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 8.36
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 8.25
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 8.11
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 7.98
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 7.94
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.92
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 7.89
Transcriptome analysis of virus infected tissues 7.74
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 7.72
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 7.58
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 7.32
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 7.32
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.27
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 7.14
Energy Metabolism during Anchorage-Independence 7.1
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 7.05
EWSR1 influences alternative splicing through direct and indirect mechanisms 7.02
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 6.92
Human neutrophil genome during PMA- and E. coli encounter-induced activation 6.81
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 6.81
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 6.67
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 6.61
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 6.45
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 6.43
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.41
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.26
IDH3a KO RNA-seq 6.09
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 6.04
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 5.99
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 5.87
Gene expression changes after LOC550643 silencing 5.84
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 5.82
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 5.82
RNA m5C Methylation in breast cancer using MeRIP-Seq 5.79
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 5.78
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 5.57
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 5.49
HEXIM1 is induced by DHODH inhibition to suppress melanoma 5.49
LncRNA-GAS5 negative regulation of YAP-target genes expression 5.4
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.37
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.3
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 5.24
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 5.24
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 5.22
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 5.15
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 5.15
Triple vectors expand AAV transfer capacity in the retina 5.12
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 5.09
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.04
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 5.0
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.98
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.94
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.94
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.94
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.93
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.93
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 4.65
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 4.63
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 4.63
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 4.56
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.52
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 4.48
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 4.37
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 4.37
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 4.36
Transcriptome of EBV-infected gastric cancer cell lines 4.11
Stem and effector CD8 T-cells from human cancers 4.08
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 4.06
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.05
Evolution of a transcriptional regulator from a transmembrane nucleoporin 4.04
RNA-seq in HepG2 and IMR90 cells 4.04
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 4.02
NR2F2 study 4.02
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.98
Capturing the Interactome of Newly Transcribed RNA 3.98
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 3.93
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.92
RNA-sequencing 3.91
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.88
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 3.88
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 3.86
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 3.85
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 3.83
RNA seq with AML (NB4) cells upon FTO inhibition 3.82
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 3.81
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 3.81
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 3.79
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 3.77
Genome wide expression change in LCC2 and MCF-7 cells 3.75
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 3.66
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 3.57
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 3.56
Reassessment of Exosome Composition 3.55
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 3.52
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.46
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 3.43
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 3.43
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 3.43
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 3.42
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.38
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.38
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 3.36
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 3.35
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.34
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.34
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 3.34
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.33
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.33
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 3.32
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.27
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.27
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.27
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.24
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 3.22
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 3.22
Iron response of HepG2 cells 3.21
RNA-Seq analysis of human colorectal cancer with liver metastasis 3.19
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.15
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.14
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 3.1
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.09
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 3.07
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.03
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.02
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.02
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.02
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 2.99
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 2.99
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.98
Gene expression in GBM with Cav3.2 inhibition 2.96
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.9
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.9
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.86
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.86
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 2.84
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.82
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 2.82
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 2.8
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 2.79
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.79
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 2.77
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 2.77
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.74
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 2.74
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.74
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.74
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.73
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.7
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 2.69
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.69
RNA polymerase in pre-B-ALL cell lines 2.66
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 2.65
Transcriptome analysis of human lung epithelial cells 2.64
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 2.59
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.58
Global analysis of alternative splicing regulated by RBM10 2.57
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.56
RNA-Seq of PRMT1 overexpression ECA109 cells 2.54
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 2.53
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 2.53
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.52
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.52
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 2.51
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.51
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.51
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.51
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 2.51
HNRNPL and its RNA Targets in Prostate Cancer 2.51
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.5
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.47
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.47
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 2.47
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 2.47
A prostate cancer chromatin interaction map 2.45
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.43
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.41
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 2.39
Rorc disruption in human FG pancreatic cancer cells 2.39
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 2.38
Accurate annotation of human protein-coding small open reading frames 2.38
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 2.36
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 2.34
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.33
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.32
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.32
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.3
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 2.29
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 2.29
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 2.29
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 2.28
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.27
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.26
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 2.26
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.24
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 2.22
T47D RNA-seq and ChrRNA-seq data 2.22
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 2.22
RNA-seq differential expression studies: more sequence, or more replication? 2.22
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 2.19
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 2.19
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.18
Gene expression profile of human placenta from T. Cruzi infected mothers 2.15
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.13
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 2.13
Epigenomic landscape during organ formation in human early embryos 2.13
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.13
Androgen Receptor-regulated genes in prostate cancer cells 2.13
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.12
The effect of PPARG inhibition on human angiomyolipoma cells 2.1
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.1
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 2.05
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.03
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 2.02
circNFIB suppresses lymphatic metastasis of pancreatic cancer 2.02
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.02
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.0
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.99
NRDE2 negatively regulates nuclear exosome functions 1.99
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.98
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 1.98
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.97
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.96
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 1.96
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 1.93
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 1.91
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.9
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 1.86
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 1.86
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 1.86
Hepatitis C virus functionally sequesters miR-122 1.85
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 1.85
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 1.84
HNF1A deficiency impairs β-cell fate, granule maturation and function 1.8
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.78
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.77
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.77
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.77
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 1.77
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.74
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.74
KSDM1b Role in Ewing Sarcoma 1.74
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.74
Noncoding regions are the main source of targetable tumor-specific antigens 1.74
Global epigenomic reconfiguration during mammalian brain development 1.7
Transcriptome-wide modulation of splicing by the exon junction complex 1.7
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.69
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.68
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 1.68
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.67
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.67
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.67
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.67
Neonatal and adult human testis defined at the single-cell level 1.64
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.64
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 1.63
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.61
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.61
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.61
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 1.6
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.58
HEK293 Heat-shock experiment 1.56
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.54
Regulation of highly expressed hCINAP on translatome 1.54
TT-Seq captures the human transient transcriptome 1.53
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.53
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.5
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 1.49
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.49
Genome-wide discovery of human splicing branchpoints 1.46
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.45
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 1.44
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.39
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 1.34
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 1.31
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.29
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.28
PRDM1 inhibits proliferation of human colon cancer organoids 1.26
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.26
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.24
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.24
Studying the selectivity of a small molecule Synucleozid on transcriptome 1.23
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.23
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.23
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.22
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.22
Transcriptome analyses of human pancreatic islets and pseudoislets 1.2
Searching for target genes of miR-508/509/506/514 in HCT116 cells 1.2
Effect of FGF13 depletion on the H460 cell line 1.18
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.18
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 1.18
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.18
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.17
RNA seq analysis of human Fetal and adult derived Enterospheres 1.17
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.16
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.16
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.14
Genome-wide discovery of human splicing branchpoints [RNAse] 1.12
RNA seq_PDX2_SHP099 1.12
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.11
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.11
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.09
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 1.09
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.08
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.08
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.07
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.06
Differences in miRNA Detection Levels are Technology and Sequence Dependent 1.06
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 1.06
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 1.06
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.05
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 1.05
Transcriptional profiling of microglia; current state of the art and future perspectives 1.04
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 1.04
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 1.04
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.03
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.99
Gene expression analysis of breast cancer cell-lines 0.99
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.98
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.98
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.97
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.97
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.96
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.96
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.96
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.96
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.95
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.94
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.93
The role of the Calcium-Sensing receptor in colorectal cancer 0.93
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.92
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.91
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.9
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.9
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.89
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.89
RNA sequencing of human pancreatic cancer cell lines 0.89
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.89
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.88
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.87
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.87
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 0.87
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 0.87
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.87
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.86
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.85
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 0.85
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.85
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.85
An optimization system for isolating and sequencing of single human colon cancer cells 0.84
Gene expression analysis upon mtDNA depletion 0.83
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.83
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.82
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.81
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.81
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.8
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.8
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.8
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.8
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.79
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 0.78
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 0.78
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.77
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.77
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.77
The pause-initiation limit restricts transcription activation in human cells 0.75
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.74
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.73
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.73
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.72
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.71
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.7
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 0.69
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.69
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.65
Preclinical model of obesity and ER-positive breast cancer 0.64
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.64
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.61
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.61
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.6
Gene expression analysis of human adenomas. 0.6
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.58
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.58
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.58
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.57
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.56
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.55
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.55
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 0.54
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.54
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.54
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.47
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.47
Transcriptome landscape of HeLa response upon triamcinolone acetonide 0.47
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.47
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.47
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.46
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.44
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.43
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.42
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.42
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.41
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.39
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.38
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.37
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.37
Identification of renal resident macrophages across species [C1] 0.37
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.37
RNA-seq data 0.37
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.37
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.36
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.35
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.35
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.35
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.35
Deep RNA sequencing of the human placental transcriptome 0.34
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.34
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.33
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.32
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.29
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.28
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.28
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.28
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.26
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.26
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.25
Human Tfh cell RNA bulk sequencing 0.25
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.24
Recovery and analysis of nascent RNA 0.24
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.24
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.22
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.22
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.22
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.21
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.21
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.21
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 0.2
Effect of drugs on transcriptomic profiles 0.18
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.18
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.14
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.14
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.14
RNA-seq of SCLC PDX models treated with EP 0.14
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.13
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.13
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.12
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.12
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.12
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.11
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.09
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.09
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 0.09
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.08
A single-cell transcriptome atlas of the human pancreas 0.08
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.07
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.06
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.04
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.04
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.04
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.03
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.02
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.02
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.02
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.02
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.01
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.01
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.01
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.01
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.0
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation